ICAD Icad Inc

icad Inc is a provider of image analysis, work flow solutions and radiation therapy for early identification and treatment of cancer. The company has cancer detection and cancer therapy segments.

$18.45  -0.28 (-1.50%)
As of 04/09/2021 15:59:52 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Health Information Services
Index country:  USA
Country of incorporation:  USA
IPO date:  08/03/2001
Outstanding shares:  24,918,458
Average volume:  216,230
Market cap:   $462,237,396
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    44934S206
ISIN:        US44934S2068
Sedol:      B83YYY6
Valuation   (See tab for details)
PE ratio:   -26.25
PB ratio:   14.29
PS ratio:   15.56
Return on equity:   -57.69%
Net income %:   -59.30%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy